Clinical Trial Update: The Role of Colchicine in Reducing The Rate of Myocardial Reperfusion Injury [Phase 3]

View source ↗

Summary

Phase 3 trial update on colchicine to reduce myocardial reperfusion injury, status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Reperfusion Injury

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Indonesia University | Conditions: Reperfusion Injury, Myocardial | Phase 3 | Status: UNKNOWN